# Lead4Life

**Funder:** KWF
**Budget:** €0.5M–€2M per project (total PPP subsidy budget €5M)
**Deadline:** 22 September 2026 (12:00 noon; full-proposal phase only (matchmaking phase precedes))
**Duration:** Up to 4 years
**Consortium:** Required — public-private partnership consortium; Consortium Agreement between all participants is mandatory
**Application:** 2-stage: matchmaking phase → full proposal
**Frequency:** One-off
**Eligible countries:** NL
**Official call:** https://www.kwf.nl/en/forresearchers/funding/lead4life
**Last verified:** 5 July 2026

## Eligibility & scope

Health~Holland PPP programme (KWF, NRG PALLAS, FAST, Oncode Institute) focused on lead-212 radiopharmaceuticals for cancer treatment. Proposals must address Pb-212 production/supply chain or enabling technologies for clinical introduction. Private-party co-investment required; projects must comply with Health~Holland PPP requirements and TKI-LSH budget rules. Dutch Summary reviewed by Patient Advisory Committee.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/kwf-lead4life-2026-09) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.